Almost none of the peptides above are FDA-approved drugs
The Phase 2 trial used subcutaneous injection into the abdomen, thigh, or upper arm on a rotating basis to minimize local reactions
Glucose control The SURPASS studies enrolled populations that were similar in terms of baseline HbA1c levels, which ranged from 7.9 to 8.5% [2, 3, 59,60,61] and found a statistically significant reduction in HbA1c already at the 5 mg dose, demonstrating a greater efficacy of tirzepatide compared to placebo or active comparator [2, 3, 59,60,61]
For those who've been hesitant about peptides due to the need for needles or prescription access, this capsule form opens the door to consistent, easy-to-integrate support
For acute injuries, this phase often represents the most dramatic improvement period